Sex disparities in cancer incidence by period and age.

Epidemiology and risk factors for kidney cancer. Nat Rev Urol (2010) 5.25

Association between smoking and risk of bladder cancer among men and women. JAMA (2011) 4.31

Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br J Cancer (2009) 2.33

Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull World Health Organ (2011) 2.16

Re: cancer risk in adult residents near nuclear power plants in Korea: a cohort study of 1992-2010. J Korean Med Sci (2014) 1.83

The sexual identity of adult intestinal stem cells controls organ size and plasticity. Nature (2016) 1.76

Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev (2011) 1.68

Impact of the HIV epidemic on the incidence rates of anal cancer in the United States. J Natl Cancer Inst (2012) 1.67

Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst (2010) 1.60

Immune cells have sex and so should journal articles. Endocrinology (2012) 1.58

Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias. Nat Genet (2016) 1.57

Statistics of hematologic malignancies in Korea: incidence, prevalence and survival rates from 1999 to 2008. Korean J Hematol (2012) 1.56

Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. Oncotarget (2012) 1.55

The Danish cancer pathway for patients with serious non-specific symptoms and signs of cancer-a cross-sectional study of patient characteristics and cancer probability. BMC Cancer (2015) 1.38

Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol (2012) 1.30

Sex differences in immune responses. Nat Rev Immunol (2016) 1.29

Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid (2010) 1.28

Gender differences in cancer susceptibility: an inadequately addressed issue. Front Genet (2012) 1.26

Enigmatic sex disparities in cancer incidence. Eur J Epidemiol (2012) 1.14

Concern A review of the epidemiology of oral and pharyngeal carcinoma: update. Head Neck Oncol (2012) 1.12

An international comparison of male and female breast cancer incidence rates. Int J Cancer (2012) 1.09

Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin. Thyroid (2013) 1.04

Small intestinal cancer: a population-based study of incidence and survival patterns in the United States, 1992 to 2006. Cancer Epidemiol Biomarkers Prev (2010) 1.00

Sociodemographic Predictors of Survival in Differentiated Thyroid Cancer: Results from the SEER Database. ISRN Endocrinol (2012) 0.98

Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes. Am J Hematol (2010) 0.92

Adrenal tumours are more predominant in females regardless of their histological subtype: a review. World J Urol (2013) 0.91

Environmental scan of anal cancer screening practices: worldwide survey results. Cancer Med (2014) 0.90

Gender differences in colorectal cancer incidence in the United States, 1975-2006. J Womens Health (Larchmt) (2011) 0.88

Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site. Br J Haematol (2014) 0.87

Association between circulating levels of sex steroid hormones and Barrett's esophagus in men: a case-control analysis. Clin Gastroenterol Hepatol (2014) 0.87

Incidence of potentially human papillomavirus-related neoplasms in the United States, 1978 to 2007. Cancer (2013) 0.87

Sex-specific exposure prevalence of established risk factors for oesophageal adenocarcinoma. Br J Cancer (2010) 0.87

HLA complex-linked heat shock protein genes and childhood acute lymphoblastic leukemia susceptibility. Cell Stress Chaperones (2009) 0.86

Free testosterone drives cancer aggressiveness: evidence from US population studies. PLoS One (2013) 0.85

Factors that impact susceptibility to fiber-induced health effects. J Toxicol Environ Health B Crit Rev (2011) 0.84

Y genetic variation and phenotypic diversity in health and disease. Biol Sex Differ (2015) 0.84

Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals. Oncotarget (2015) 0.84

Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry. Br J Cancer (2013) 0.82

Elevated expression of H19 and Igf2 in the female mouse eye. PLoS One (2013) 0.82

Inverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis. Clin Gastroenterol Hepatol (2016) 0.81

Analysis of cancer genomes reveals basic features of human aging and its role in cancer development. Nat Commun (2016) 0.81

Biology, systematics, and clinical manifestations of Zygomycota infections. Eur J Clin Microbiol Infect Dis (2014) 0.80

17Beta-estradiol promotes aggressive laryngeal cancer through membrane-associated estrogen receptor-alpha 36. Horm Cancer (2013) 0.80

Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12. Br J Haematol (2016) 0.80

Understanding the gender disparity in bladder cancer risk: the impact of sex hormones and liver on bladder susceptibility to carcinogens. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev (2013) 0.80

Aging and cancer mortality: dynamics of change and sex differences. Exp Gerontol (2012) 0.79

Obesity and the Incidence of Upper Gastrointestinal Cancers: An Ecological Approach to Examine Differences across Age and Sex. Cancer Epidemiol Biomarkers Prev (2015) 0.79

Diagnosed hematological malignancies in Bangladesh - a retrospective analysis of over 5000 cases from 10 specialized hospitals. BMC Cancer (2014) 0.78

Gender differences in chemical carcinogenesis in National Toxicology Program 2-year bioassays. Toxicol Pathol (2012) 0.78

Trends and variations in breast and colorectal cancer incidence from 1995 to 2011: a comparative study between Texas Cancer Registry and National Cancer Institute's Surveillance, Epidemiology and End Results data. Int J Oncol (2015) 0.77

Common genetic variants in sex hormone pathway genes and papillary thyroid cancer risk. Thyroid (2012) 0.77

Clinical-pathological characteristics and prognosis of a cohort of oesophageal cancer patients: a competing risks survival analysis. J Epidemiol (2015) 0.77

The inverse relationship between bladder and liver in 4-aminobiphenyl-induced DNA damage. Oncotarget (2015) 0.77

Estrogen Enhances Esophageal Barrier Function by Potentiating Occludin Expression. Dig Dis Sci (2015) 0.76

A global assessment of the male predominance in esophageal adenocarcinoma. Oncotarget (2016) 0.76

A population-based study of incidence and patient survival of small cell carcinoma in the United States, 1992-2010. BMC Cancer (2015) 0.76

The Effects of Intravenous Lidocaine Infusions on the Quality of Recovery and Chronic Pain After Robotic Thyroidectomy: A Randomized, Double-Blinded, Controlled Study. World J Surg (2016) 0.75

Smoking-attributable mortality in American Indians: findings from the Strong Heart Study. Eur J Epidemiol (2015) 0.75

A childhood acute lymphoblastic leukemia genome-wide association study identifies novel sex-specific risk variants. Medicine (Baltimore) (2016) 0.75

Epidemiology: Excess cancer in men--a call for an increased research focus. Nat Rev Clin Oncol (2013) 0.75

Non-Hodgkin lymphoma in early life. J Natl Cancer Inst (2012) 0.75

Male-to-female sex ratios of abnormalities detected by fluorescence in situ hybridization in a population of chronic lymphocytic leukemia patients. Hematol Rep (2013) 0.75

The frequency of histologically confirmed Barrett's esophagus varies by the combination of ethnicity and gender. J Gastrointest Oncol (2017) 0.75

Sex steroid hormones in relation to Barrett's esophagus: an analysis of the FINBAR Study. Andrology (2017) 0.75

Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients. BMC Cancer (2014) 0.75

Sex chromosomes drive gene expression and regulatory dimorphisms in mouse embryonic stem cells. Biol Sex Differ (2017) 0.75

Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030. Am J Gastroenterol (2017) 0.75

Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med (2003) 35.39

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology (2007) 26.78

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med (2006) 18.63

Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med (2007) 16.39

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science (2007) 12.91

Constructions of masculinity and their influence on men's well-being: a theory of gender and health. Soc Sci Med (2000) 10.67

Cigarette smoking among adults--United States, 2006. MMWR Morb Mortal Wkly Rep (2007) 8.14

Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst (1998) 4.42

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol (2006) 4.17

Sex-specific genetic architecture of human disease. Nat Rev Genet (2008) 4.01

Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer (2004) 3.40

Sex hormones and the immune response in humans. Hum Reprod Update (2005) 3.13

Gender differences in the disposition and toxicity of metals. Environ Res (2006) 2.91

Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer (2005) 2.73

Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer (2004) 2.59

Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev (2006) 2.59

The sex differential in morbidity, mortality, and lifestyle. Annu Rev Public Health (1984) 2.54

Men: good health and high mortality. Sex differences in health and aging. Aging Clin Exp Res (2008) 2.33

A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol (2007) 2.31

Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc (2007) 2.18

Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev (2008) 1.89

Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol (2006) 1.87

Intra-abdominal pressure, sagittal abdominal diameter and obesity comorbidity. J Intern Med (1997) 1.72

Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol (2008) 1.65

A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol (2005) 1.63

Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer (2008) 1.48

Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands. Eur J Cancer Prev (2000) 1.42

Epidemiology and primary prevention of thyroid cancer. Thyroid (2002) 1.41

Increasing incidence of squamous cell carcinoma of the anus in Scotland, 1975-2002. Br J Cancer (2006) 1.33

Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy. Ann Epidemiol (2005) 1.24

Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway. Cell Prolif (2007) 1.19

Exploring the biological contributions to human health: does sex matter? J Womens Health Gend Based Med (2001) 1.17

Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. Br J Cancer (2006) 1.16

Characteristics of gastroesophageal reflux disease in Japan: increased prevalence in elderly women. J Gastroenterol (2003) 1.15

Sex hormones and oesophageal adenocarcinoma: influence of childbearing? Br J Cancer (2005) 1.08

Risk factors for adult renal cell carcinoma. Urol Clin North Am (2004) 1.06

Ultraviolet radiation and malignant melanoma. Adv Exp Med Biol (2008) 1.05

Sex differences in the incidence of tumours at various sites. Br J Cancer (1969) 0.99

Role of hiatus hernia and gastric mucosal atrophy in the development of reflux esophagitis in the elderly. J Gastroenterol Hepatol (2001) 0.99

Sex-specific risk factor profile in oesophageal adenocarcinoma. Br J Cancer (2008) 0.99

Male reproductive strategy and decreased longevity. Acta Biotheor (1998) 0.96

Barrett's esophagus in females: a comparative analysis of risk factors in females and males. Am J Gastroenterol (2005) 0.95

The sex ratio of mortality and its secular trends. Int J Epidemiol (1995) 0.95

Sex chromosome alterations associate with tumor progression in sporadic colorectal carcinomas. Clin Cancer Res (2007) 0.93

Trends in cancer mortality sex ratios in Europe, 1950-1989. World Health Stat Q (1992) 0.92

Sex differentials in cancer mortality and morbidity. World Health Stat Q (1978) 0.85

Analyses of changes in the ratios of male-to-female cancer mortality. A hypothesis-generating exercise. Ann N Y Acad Sci (1990) 0.85

Identification of risk factors for specific subsites within the oral and oropharyngeal region--a study of 647 cancer patients. Indian J Cancer (2002) 0.84

What gender differences in cancer incidence changed during the last 10 years in central Italy? Tumori (2002) 0.83

Social sexual inequality and sex difference in cancer incidence. Environ Res (2006) 0.83

Case-control study of oropharyngeal cancer. Cancer Detect Prev (2006) 0.83

Is there a gender difference in the effect of antioxidants on cancer risk? Br J Nutr (2005) 0.82

Gender differences in gastroesophageal reflux disease. J Gend Specif Med (2001) 0.80

On the sex ratio of all-cause and disease-specific mortality rates worldwide. Verh K Acad Geneeskd Belg (2007) 0.78

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol (2009) 9.84

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood (2005) 8.37

Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev (2009) 8.08

50-year trends in smoking-related mortality in the United States. N Engl J Med (2013) 7.80

The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med (2003) 6.06

Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst (2008) 6.00

Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ (2009) 5.79

Smoking and mortality--beyond established causes. N Engl J Med (2015) 5.54

Epidemiology and risk factors for kidney cancer. Nat Rev Urol (2010) 5.25

Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer (2005) 4.69

Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet (2005) 4.15

Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst (2005) 4.14

Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology (2010) 3.98

New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst (2006) 3.90

Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69

Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am (2002) 3.69

Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J Natl Cancer Inst (2012) 3.69

Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet (2012) 3.68

A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet (2010) 3.53

Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med (2004) 3.52

Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood (2011) 3.30

Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology (2004) 3.30

Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology (2005) 3.24

Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology (2011) 3.24

Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004. Br J Haematol (2008) 3.21

Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst (2006) 3.17

Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol (2005) 3.01

Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst (2006) 2.97

Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics. Cancer (2012) 2.95

Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol (2009) 2.93

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol (2007) 2.90

Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol (2013) 2.89

Tooth loss is associated with increased risk of total death and death from upper gastrointestinal cancer, heart disease, and stroke in a Chinese population-based cohort. Int J Epidemiol (2005) 2.87

Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. J Hepatol (2005) 2.85

Environmental causes of esophageal cancer. Gastroenterol Clin North Am (2009) 2.80

Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26,758 cases. Int J Cancer (2006) 2.73

Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol (2003) 2.68

Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst (2004) 2.60

Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat (2005) 2.57

Outcomes from a prospective trial of endoscopic radiofrequency ablation of early squamous cell neoplasia of the esophagus. Gastrointest Endosc (2011) 2.55

Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. J Clin Oncol (2003) 2.50

Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid (2010) 2.48

US lung cancer trends by histologic type. Cancer (2014) 2.46

Trends in the incidence of testicular germ cell tumors in the United States. Cancer (2003) 2.45

Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst (2009) 2.43

Contemporary epidemiology of renal cell cancer. Cancer J (2008) 2.40

Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst (2002) 2.38

Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer (2011) 2.23

Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J Natl Cancer Inst (2003) 2.19

Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. Carcinogenesis (2009) 2.17

Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood (2009) 2.16

Index-based dietary patterns and risk of incident hepatocellular carcinoma and mortality from chronic liver disease in a prospective study. Hepatology (2014) 2.14

Body mass index and risk of lung cancer among never, former, and current smokers. J Natl Cancer Inst (2012) 2.13

Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood (2010) 2.12

Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol (2009) 2.10

AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology? Blood (2010) 2.10

Prospective study of serum 25-hydroxyvitamin D concentration and mortality in a Chinese population. Am J Epidemiol (2012) 2.08

Opium use and risk of mortality from digestive diseases: a prospective cohort study. Am J Gastroenterol (2013) 2.07

Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50,000 adults in Iran. BMJ (2012) 2.07

International trends in the incidence of testicular cancer, 1973-2002. Cancer Epidemiol Biomarkers Prev (2010) 2.07

The gastro-esophageal malignancies in Northern Iran research project: impact on the health research and health care systems in Iran. Arch Iran Med (2013) 2.01

Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey. Prev Med (2004) 2.00

Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. Nat Genet (2012) 2.00

Genome-wide association study of glioma and meta-analysis. Hum Genet (2012) 1.96

Esophageal cancer in Northeastern Iran: a review. Arch Iran Med (2007) 1.95

Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol Biomarkers Prev (2004) 1.95

Characteristics of childhood cancer survivors predicted their successful tracing. J Clin Epidemiol (2004) 1.94

A geographic analysis of prostate cancer mortality in the United States, 1970-89. Int J Cancer (2002) 1.94

Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population. J Hypertens (2013) 1.86

Lung cancer rates convergence in young men and women in the United States: analysis by birth cohort and histologic type. Int J Cancer (2003) 1.85

Rising prostate cancer rates in South Korea. Prostate (2006) 1.83

Association of meat and fat intake with liver disease and hepatocellular carcinoma in the NIH-AARP cohort. J Natl Cancer Inst (2010) 1.81

Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev (2009) 1.78

Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol (2009) 1.77

Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat Genet (2013) 1.74

Cutaneous soft tissue sarcoma incidence patterns in the U.S. : an analysis of 12,114 cases. Cancer (2008) 1.74

Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev (2014) 1.73

Trends in the incidence of ocular melanoma in the United States, 1974-1998. Cancer Causes Control (2003) 1.72

Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern Iran. Gut (2010) 1.71

Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res (2010) 1.68

Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev (2011) 1.68

Prospective study of serum vitamin E levels and esophageal and gastric cancers. J Natl Cancer Inst (2003) 1.68

Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008. Hepatology (2012) 1.68

Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat (2004) 1.67

Comparison of occupational exposure assessment methods in a case-control study of lead, genetic susceptibility and risk of adult brain tumours. Occup Environ Med (2010) 1.66

Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J Clin Nutr (2004) 1.65

Brain cancer incidence trends in relation to cellular telephone use in the United States. Neuro Oncol (2010) 1.63

Zinc concentration in esophageal biopsy specimens measured by x-ray fluorescence and esophageal cancer risk. J Natl Cancer Inst (2005) 1.63

History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer (2002) 1.62